Damanti, S. et al. Evaluation of muscle mass and stiffness with limb ultrasound in COVID-19 survivors. Front. Endocrinol. 0, 164 (2022).
Zhang, X.-M. et al. Sarcopenia as a predictor of mortality among the critically ill in an intensive care unit: A systematic review and meta-analysis. BMC Geriatr. 21, 339 (2021).
Nijholt, W., Jager-Wittenaar, H., Raj, I. S., van der Schans, C. P. & Hobbelen, H. Reliability and validity of ultrasound to estimate muscles: A comparison between different transducers and parameters. Clin. Nutr. ESPEN 35, 146–152 (2020).
Joskova, V. et al. Critical evaluation of muscle mass loss as a prognostic marker of morbidity in critically ill patients and methods for its determination. J. Rehabil. Med. 50, 696–704 (2018).
Schefold, J. C. et al. Muscular weakness and muscle wasting in the critically ill. J. Cachexia. Sarcopenia Musc. 11, 1399–1412 (2020).
Chapple, L. S., Parry, S. M. & Schaller, S. J. Attenuating muscle mass loss in critical illness: The role of nutrition and exercise. Curr. Osteoporos. Rep. 20, 290–308 (2022).
Gustafson, O. D., Williams, M. A., McKechnie, S., Dawes, H. & Rowland, M. J. Musculoskeletal complications following critical illness: A scoping review. J. Crit. Care 66, 60–66 (2021).
Ali, A. M. & Kunugi, H. Skeletal muscle damage in COVID-19: A call for action. Medicina (Kaunas, Lithuania) 57, (2021).
Baj, J. et al. COVID-19: specific and non-specific clinical manifestations and symptoms: The current state of knowledge. J. Clin. Med. 9, 1–22 (2020).
Torbic, H., Krishnan, S., Harnegie, M. P. & Duggal, A. Neuromuscular blocking agents for ARDS: A systematic review and meta-analysis. Respir. Care 66, 120–128 (2021).
Soares, M. N. et al. Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19. J. Cachexia. Sarcopenia Musc. 13, 11–22 (2022).
Early neuromuscular blockade in the acute respiratory distress syndrome. N. Engl. J. Med. 380, 1997–2008 (2019).
Pescaru, C. C. et al. The effects of COVID-19 on skeletal muscles, muscle fatigue and rehabilitation programs outcomes. Medicina (Kaunas) 58, 1199 (2022).
Keyhanian, K. et al. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J. Neuroimmunol. 350, (2020).
Ramani, S. L. et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 50, 1763–1773 (2021).
Bragança, R. D. et al. Use of handgrip dynamometry for diagnosis and prognosis assessment of intensive care unit acquired weakness: A prospective study. Heart Lung 48, 532–537 (2019).
Pardo, E. et al. Reliability of ultrasound measurements of quadriceps muscle thickness in critically ill patients. BMC Anesthesiol. 18, 205 (2018).
Casey, P. et al. The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: A systematic review. J. Cachexia Sarcopenia Musc. 13, 2298–2309 (2022).
Weinel, L. M., Summers, M. J. & Chapple, L.-A. Ultrasonography to measure quadriceps muscle in critically ill patients: A literature review of reported methodologies. Anaesth. Intensive Care 47, 423–434 (2019).
Ong, C., Lee, J. H., Leow, M. K. S. & Puthucheary, Z. A. Skeletal muscle ultrasonography in nutrition and functional outcome assessment of critically Ill children: Experience and insights from pediatric disease and adult critical care studies. J. Parenter. Enter. Nutr. 41, 1091–1099 (2017).
Hogenbirk, R. N. M. et al. Thickness of biceps and quadriceps femoris muscle measured using point-of-care ultrasound as a representation of total skeletal muscle mass. J. Clin. Med. 11, 6606 (2022).
Carámbula, A., Visca, A., D’Amico, S. & Angulo, M. Respiratory and peripheral muscle assessment in the intensive care unit. Archivos de Bronconeumología (English Edition) 55, 258–265 (2019).
Formenti, P., Umbrello, M., Coppola, S., Froio, S. & Chiumello, D. Clinical review: Peripheral muscular ultrasound in the ICU. Ann. Intensive Care 9. https://doi.org/10.1186/s13613-019-0531-x (2019).
Mourtzakis, M., Parry, S., Connolly, B. & Puthucheary, Z. Skeletal muscle ultrasound in critical care: A tool in need of translation. Ann. Am. Thorac. Soc. 14, 1495–1503 (2017).
Narici, M. et al. Age-related alterations in muscle architecture are a signature of sarcopenia: The ultrasound sarcopenia index. J. Cachexia Sarcopenia Musc. 12, 973–982 (2021).
Zambon, M. et al. Assessment of diaphragmatic dysfunction in the critically ill patient with ultrasound: A systematic review. Intens. Care Med. 43, 29–38 (2017).
Burgess, L. C. et al. Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: A narrative review. J. Rehabil. Med. 53, (2021).
Wang, J. et al. Effects of early mobilization on the prognosis of critically ill patients: A systematic review and meta-analysis. Int. J. Nurs. Stud. 110, (2020).
Andrade-Junior, M. C. de et al. Skeletal muscle wasting and function impairment in intensive care patients with severe COVID-19. Front. Physiol. 12, (2021).
Formenti, P. et al. Respiratory and peripheral muscular ultrasound characteristics in ICU COVID 19 ARDS patients. J. Crit. Care 67, 14 (2022).
Suh, J. et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology 97, e849–e858 (2021).
Willemse, L., Wouters, E. J. M., Pisters, M. F. & Vanwanseele, B. Intra-assessor reliability and measurement error of ultrasound measures for foot muscle morphology in older adults using a tablet-based ultrasound machine. J. Foot Ankle Res. 15, 6 (2022).
Bierbrauer, J. et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit. Care Med. 40, 647–650 (2012).
Baldwin, C. E. & Bersten, A. D. Alterations in respiratory and limb muscle strength and size in patients with sepsis who are mechanically ventilated. Phys. Ther. 94, 68–82 (2014).
Doiron, K. A., Hoffmann, T. C. & Beller, E. M. Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit. Cochrane Database Syst. Rev. 3, CD010754 (2018).
Paliwal, V. K., Garg, R. K., Gupta, A. & Tejan, N. Neuromuscular presentations in patients with COVID-19. Neurol. Sci. 41, 3039–3056 (2020).
Friedrich, O. et al. The sick and the weak: Neuropathies/myopathies in the critically Ill. Physiol. Rev. 95, 1025–1109 (2015).
Puthucheary, Z. A. et al. Acute skeletal muscle wasting in critical illness. JAMA 310, 1591–1600 (2013).
Turton, P., Hay, R., Taylor, J., McPhee, J. & Welters, I. Human limb skeletal muscle wasting and architectural remodeling during five to ten days intubation and ventilation in critical care—an observational study using ultrasound. BMC Anesthesiol. 16, 1–8 (2016).
Tw, B. et al. Age-related differences in lower extremity tissue compartments and associations with physical function in older adults. Exp. Gerontol. 47, (2012).
Pojednic, R. M. et al. The specific contributions of force and velocity to muscle power in older adults. Exp. Gerontol. 47, 608–613 (2012).
Dufour, A. B., Hannan, M. T., Murabito, J. M., Kiel, D. P. & McLean, R. R. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: The Framingham Study. J. Gerontol. A Biol. Sci. Med. Sci. 68, 168–174 (2013).
Venturelli, M. et al. Cellular aging of skeletal muscle: telomeric and free radical evidence that physical inactivity is responsible and not age. Clin. Sci. (Lond) 127, 415–421 (2014).
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M. & Perlman, S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 82, 7264–7275 (2008).
Sedaghat, Z. & Karimi, N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J. Clin. Neurosci. 76, 233–235 (2020).
Toscano, G. et al. Guillain-Barré syndrome associated with SARS-CoV-2. N. Engl. J. Med. 382, 2574–2576 (2020).
Paolo, F. et al. The possible predictive value of muscle ultrasound in the diagnosis of ICUAW in long-term critically ill patients. J. Crit. Care 71, 154104 (2022).
Qin, E. S., Hough, C. L., Andrews, J. & Bunnell, A. E. Intensive care unit-acquired weakness and the COVID-19 pandemic: A clinical review. PM R 14, 227–238 (2022).
Annane, D. What is the evidence for harm of neuromuscular blockade and corticosteroid use in the intensive care unit?. Semin. Respir. Crit. Care Med. 37, 51–56 (2016).
Gruther, W. et al. Muscle wasting in intensive care patients: Ultrasound observation of the M. quadriceps femoris muscle layer. J. Rehab. Med. 40, 185–189 (2008).
Needham, D. M. et al. Risk factors for physical impairment after acute lung injury in a national, multicenter study. Am. J. Respir. Crit. Care Med. 189, 1214–1224 (2014).
Tardif, N., Grip, J. & Rooyackers, O. Muscle metabolism. Curr. Opin. Crit. Care 23, 264–268 (2017).